Serum B vitamin levels and risk of lung cancer

JAMA

Volumn 303, Issue 23, 2010, Pages 2377-2385

  Johansson, Mattias ^a   Relton, Caroline ^a   Ueland, Per Magne ^a   Vollset, Stein Emil ^a   Midttun, Øivind ^a   Nygård, Ottar ^a   Slimani, Nadia ^a   Boffetta, Paolo ^a   Jenab, Mazda ^a   Clavel Chapelon, Françoise ^a   Boutron Ruault, Marie Christine ^a   Fagherazzi, Guy ^a   Kaaks, Rudolf ^a   Rohrmann, Sabine ^a   Boeing, Heiner ^a   Weikert, Cornelia ^a   Bas Buenode Mesquita, H ^a   Ros, Martine M ^a   Van Gils, Carla H ^a   Peeters, Petra H M ^a   Agudo, Antonio ^a   Barricarte, Aurelio ^a   Navarro, Carmen ^a   Rodríguez, Laudina ^a   Sánchez, Maria José ^a   Larrañaga, Nerea ^a   Khaw, Kay Tee ^a   Wareham, Nick ^a   Allen, Naomi E ^a   Crowe, Francesca ^a   Gallo, Valentina ^a   Norat, Teresa ^a   Krogh, Vittorio ^a   Masala, Giovanna ^a   Panico, Salvatore ^a   Sacerdote, Carlotta ^a   Tumino, Rosario ^a   Trichopoulou, Antonia ^a   Lagiou, Pagona ^a   Trichopoulos, Dimitrios ^a   Rasmuson, Torgny ^a   Hallmans, Göran ^a   Riboli, Elio ^a   Vineis, Paolo ^a   Brennan, Paul ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; COTININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; RIBOFLAVIN; VITAMIN B GROUP; VITAMIN B COMPLEX;

ADULT; AGED; ARTICLE; BLOOD DONOR; CANCER INCIDENCE; CANCER RISK; CARBON METABOLISM; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING HABIT; VITAMIN BLOOD LEVEL; BLOOD; COHORT ANALYSIS; EUROPE; INCIDENCE; LUNG TUMOR; MIDDLE AGED; RISK;

ADULT; AGED; COHORT STUDIES; EUROPE; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; METHIONINE; MIDDLE AGED; ODDS RATIO; RISK; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 77953633351     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.808     Document Type: Article

References (47)

1. Kim YI. Folate and colorectal cancer. Mol Nutr Food Res. 2007;51(3):267-292.
2. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22(22):4632-4642.
3. NIH Office of Dietary Supplements. Dietary Supplement Fact Sheets. http://ods.od.nih.gov/Health-Information/Information-About-Individual-Dietary- Supplements.aspx. Accessed May 25, 2010.
4. 12 and C in 10 countries in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr. 2009; 63(suppl 4):s122-s149.
5. Laufer EM, Hartman TJ, Baer DJ, et al. Effects of moderate alcohol consumption on folate and vitamin B(12) status in postmenopausal women. Eur J Clin Nutr. 2004; 58(11):1518-1524.
6. Gibson A, Woodside JV, Young IS, et al. Alcohol increases homocysteine and reduces B vitamin concentration in healthy male volunteers. QJM. 2008;101 (11):881-887.
7. Weisberg IS, Jacques PF, Selhub J, et al. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR). Atherosclerosis. 2001;156(2):409-415.
8. 12, folate, and homocysteine blood concentrations. Am J Hum Genet. 2009;84(4):477-482.
9. Dierkes J, Weikert C, Klipstein-Grobusch K, et al. Plasma pyridoxal-5-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort. Am J Clin Nutr. 2007;86(1):214-220. (Pubitemid 47041613)
10. Ames BN, Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer. 2002; 2(9):694-704. (Pubitemid 37328920)
11. Cole BF, Baron JA, Sandler RS, et al; Polyp Prevention Study Group. Folic acid for the prevention of colorectal adenomas. JAMA. 2007;297(21):2351-2359.
12. Logan RF, Grainge MJ, Shepherd VC, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology. 2008;134(1):29-38. (Pubitemid 350309319)
13. Hartman TJ, Woodson K, Stolzenberg-Solomon R, et al. Association of the B-vitamins pyridoxal 5′phosphate (B(6)), B(12), and folate with lung cancer risk in older men. Am J Epidemiol. 2001;153(7):688-94.
14. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113-1124. (Pubitemid 36313608)
15. Midttun Ø, Hustad S, Ueland PM. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009;23(9):1371-1379.
16. Ueland PM, Midttun O, Windelberg A, et al. Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry. Clin Chem Lab Med. 2007;45(12): 1737-1745. (Pubitemid 350232967)
17. Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol. 1997; 281:43-53.
18. Ueland P. Folate in serum. http://folk.uib.no/mfapu/Pages/BV/BVSite/ Pages/analyte-info/s-folate.html. Accessed December 1 2009.
19. 12 performed in 96-well microtitre plates. J Clin Pathol. 1991;44(7):592-595.
20. Bray F. Chapter eight, age-standardization. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents Vol VIII. Lyon, France: IARC Scientific Publications; 2002: No. 155.
21. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950. BMJ. 2000;321(7257):323-329.
22. 12, and their associations with plasma homocysteine concentrations. Int J Food Sci Nutr. 2010;61(1):61-67.
23. 12 intake in women of reproductive age. Eur J Clin Nutr. 2007;61(5):610-615.
24. Willet W. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press. 1998;124-127, 202-205.
25. 12 concentrations and the risk of colorectal cancer. Int J Cancer. 2008;122(9):2057-2061.
26. 6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst. 2005;97(9): 684-692.
27. Le Marchand L, White KK, Nomura AM, et al. Plasma levels of B vitamins and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2195-2201.
28. 6 and risk of colorectal cancer in men. Cancer Epidemiol Biomarkers Prev. 2009;18(4): 1197-1202.
29. 12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2136-2145.
30. Weinstein SJ, Albanes D, Selhub J, et al. One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev. 2008; 17(11):3233-3240.
31. Vollset SE, Igland J, Jenab M, et al. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2007; 16(11):2416-2424.
32. 12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res. 2007;67(11):5553-5560.
33. Johansson M, Van Guelpen B, Vollset SE, et al. One-carbon metabolism and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1538-1543.
34. 12 in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17(2):279-285.
35. Chou YC, Lee MS, Wu MH, et al. Plasma homocysteine as a metabolic risk factor for breast cancer. Breast Cancer Res Treat. 2007;101(2):199-205.
36. 12, homocysteine, and risk of breast cancer. J Natl Cancer Inst. 2003;95(5):373-380.
37. 12, and risk of breast cancer in women. Am J Clin Nutr. 2008;87(3):734-743.
38. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133(11)(suppl 1): 3731s-3739s.
39. Ulrich CM, Potter JD. Folate and cancer - timing is everything. JAMA. 2007;297(21):2408-2409.
40. Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341-353. (Pubitemid 29383482)
41. Ebbing M, Bleie O, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography. JAMA. 2008;300(7):795-804.
42. 12. JAMA. 2009;302(19):2119-2126.
43. Drake BF, Colditz GA. Assessing cancer prevention studies - a matter of time. JAMA. 2009;302(19): 2152-2153.
44. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
45. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008; 40(5):616-622.
46. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers - a different disease. Nat Rev Cancer. 2007; 7(10):778-790. (Pubitemid 47463669)
47. Rudin CM, Avila-Tang E, Samet JM, et al. Lung cancer in never smokers: a call to action. Clin Cancer Res. 2009;15(18):5622-5625.